APLT
Price
$0.53
Change
+$0.04 (+8.16%)
Updated
Sep 2, 04:07 PM (EDT)
Capitalization
70.95M
65 days until earnings call
TRVI
Price
$7.26
Change
-$0.00 (-0.00%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
883.49M
64 days until earnings call
Interact to see
Advertisement

APLT vs TRVI

Header iconAPLT vs TRVI Comparison
Open Charts APLT vs TRVIBanner chart's image
Applied Therapeutics
Price$0.53
Change+$0.04 (+8.16%)
Volume$100
Capitalization70.95M
Trevi Therapeutics
Price$7.26
Change-$0.00 (-0.00%)
Volume$34.05K
Capitalization883.49M
APLT vs TRVI Comparison Chart in %
Loading...
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLT vs. TRVI commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLT is a Hold and TRVI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (APLT: $0.49 vs. TRVI: $7.26)
Brand notoriety: APLT and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLT: 31% vs. TRVI: 86%
Market capitalization -- APLT: $70.95M vs. TRVI: $883.49M
APLT [@Biotechnology] is valued at $70.95M. TRVI’s [@Biotechnology] market capitalization is $883.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLT’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • APLT’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than APLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLT’s TA Score shows that 4 TA indicator(s) are bullish while TRVI’s TA Score has 3 bullish TA indicator(s).

  • APLT’s TA Score: 4 bullish, 3 bearish.
  • TRVI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, APLT is a better buy in the short-term than TRVI.

Price Growth

APLT (@Biotechnology) experienced а -3.77% price change this week, while TRVI (@Biotechnology) price change was -3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.61%. For the same industry, the average monthly price growth was +22.15%, and the average quarterly price growth was +32.80%.

Reported Earning Dates

APLT is expected to report earnings on Nov 06, 2025.

TRVI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($883M) has a higher market cap than APLT($71M). TRVI YTD gains are higher at: 76.092 vs. APLT (-42.455). TRVI has higher annual earnings (EBITDA): -47.19M vs. APLT (-110.99M). TRVI has more cash in the bank: 204M vs. APLT (30.4M). TRVI has less debt than APLT: TRVI (891K) vs APLT (2.6M). APLT has higher revenues than TRVI: APLT (121K) vs TRVI (0).
APLTTRVIAPLT / TRVI
Capitalization71M883M8%
EBITDA-110.99M-47.19M235%
Gain YTD-42.45576.092-56%
P/E RatioN/AN/A-
Revenue121K0-
Total Cash30.4M204M15%
Total Debt2.6M891K292%
FUNDAMENTALS RATINGS
APLT vs TRVI: Fundamental Ratings
APLT
TRVI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
10066
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
5339
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRVI's Valuation (41) in the Pharmaceuticals Major industry is in the same range as APLT (73) in the null industry. This means that TRVI’s stock grew similarly to APLT’s over the last 12 months.

TRVI's Profit vs Risk Rating (66) in the Pharmaceuticals Major industry is somewhat better than the same rating for APLT (100) in the null industry. This means that TRVI’s stock grew somewhat faster than APLT’s over the last 12 months.

TRVI's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as APLT (99) in the null industry. This means that TRVI’s stock grew similarly to APLT’s over the last 12 months.

TRVI's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as APLT (53) in the null industry. This means that TRVI’s stock grew similarly to APLT’s over the last 12 months.

TRVI's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as APLT (100) in the null industry. This means that TRVI’s stock grew similarly to APLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLTTRVI
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
84%
Momentum
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 26 days ago
88%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVRMX26.14-0.12
-0.46%
Franklin Mutual Small-Mid Cap Val Adv
RGDTX11.35-0.06
-0.53%
Russell Inv Global Equity M
PXSAX18.32-0.11
-0.60%
Impax Small Cap A
FLACX84.42-0.65
-0.76%
Fidelity Advisor Stock Sel C
RIERX13.08-0.13
-0.98%
RBC International Equity R6

APLT and

Correlation & Price change

A.I.dvisor tells us that APLT and AMGXF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APLT and AMGXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLT
1D Price
Change %
APLT100%
-3.64%
AMGXF - APLT
32%
Poorly correlated
N/A
COEP - APLT
27%
Poorly correlated
+5.25%
EWTX - APLT
25%
Poorly correlated
-2.05%
EDIT - APLT
25%
Poorly correlated
-3.02%
TRVI - APLT
25%
Poorly correlated
+0.62%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with PTGX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
+0.62%
PTGX - TRVI
43%
Loosely correlated
+1.57%
BIESF - TRVI
43%
Loosely correlated
N/A
GOSS - TRVI
33%
Poorly correlated
+2.92%
MLYS - TRVI
31%
Poorly correlated
+1.71%
XENE - TRVI
28%
Poorly correlated
+0.28%
More